Molecular Detection of Cytokeratin-19–Positive Cells in the Peripheral Blood of Patients With Operable Breast Cancer: Evaluation of Their Prognostic Significance

Aliki Stathopoulou, Ioannis G. Vlachonikolis, D. Mavroudis, +8

Journal of Clinical Oncology

Predictive and Prognostic Value of Peripheral Blood Cytokeratin-19 mRNA-Positive Cells Detected by Real-Time Polymerase Chain Reaction in Node-Negative Breast Cancer Patients

N. Xenidis, Maria Perraki, Maria Kafousi, +12

Journal of Clinical Oncology

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer

Michail Ignatiadis, N. Xenidis, Maria Perraki, +10

Journal of Clinical Oncology

Cytokeratin-19 mRNA-Positive Circulating Tumor Cells After Adjuvant Chemotherapy in Patients With Early Breast Cancer

Nikolaos Xenidis, Michail Ignatiadis, Stella Apostolaki, +9

Journal of Clinical Oncology

Prognostic Value of the Molecular Detection of Circulating Tumor Cells Using a Multimarker Reverse Transcription-PCR Assay for Cytokeratin 19, Mammaglobin A, and HER2 in Early Breast Cancer

Michail Ignatiadis, Galatea Kallergi, Maria Ntoulia, +8

Clinical Cancer Research

Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.

Aliki Stathopoulou, Anna Gizi, Maria Perraki, +5

PubMed

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Vasilis Georgoulias, V. Bozionelou, Sofia Agelaki, +6

Annals of Oncology

Tumor BiologyBreast OncologyEarly Breast CancerClinical RelapsesMedicine +7

Trastuzumab Administration Can Effectively Target Chemotherapy-Resistant Cytokeratin-19 Messenger RNA–Positive Tumor Cells in the Peripheral Blood and Bone Marrow of Patients With Breast Cancer

Vassiliki Bozionellou, Dimitris Mavroudis, Maria Perraki, +6

Clinical Cancer Research

Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer

Nikolaos Xenidis, Ioannis G. Vlachonikolis, D. Mavroudis, +9

Annals of Oncology

Tumor BiologyBreast OncologyMedicineImmunologyAdjuvant Chemotherapy +9

Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer

Anna Daskalaki, Sofia Agelaki, Maria Perraki, +7

British Journal of Cancer